Latest Finepoint Capital LP Stock Portfolio
Finepoint Capital LP Performance:
2024 Q3: 0.94%YTD: -4.06%2023: 9.2%
Performance for 2024 Q3 is 0.94%, and YTD is -4.06%, and 2023 is 9.2%.
About Finepoint Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Finepoint Capital LP reported an equity portfolio of $1.4 Billions as of 30 Sep, 2024.
The top stock holdings of Finepoint Capital LP are SSNT, LBRDA, RVMD. The fund has invested 29.5% of it's portfolio in QXO INC and 11.2% of portfolio in LIBERTY BROADBAND CORP.
The fund managers got completely rid off CHURCHILL CAPITAL CORP VII (CVII), CONCORD ACQUISITION CORP II (CNDA) and CALIDI BIOTHERAPEUTICS INC (FLAG) stocks. Finepoint Capital LP opened new stock positions in QXO INC (SSNT) and CALIDI BIOTHERAPEUTICS INC (FLAG). The fund showed a lot of confidence in some stocks as they added substantially to GALAPAGOS NV, SPRINGWORKS THERAPEUTICS INC (SWTX) and RELAY THERAPEUTICS INC (RLAY).
The top stock holdings of Finepoint Capital LP are SSNT, LBRDA, RVMD. The fund has invested 29.5% of it's portfolio in QXO INC and 11.2% of portfolio in LIBERTY BROADBAND CORP.
The fund managers got completely rid off CHURCHILL CAPITAL CORP VII (CVII), CONCORD ACQUISITION CORP II (CNDA) and CALIDI BIOTHERAPEUTICS INC (FLAG) stocks. Finepoint Capital LP opened new stock positions in QXO INC (SSNT) and CALIDI BIOTHERAPEUTICS INC (FLAG). The fund showed a lot of confidence in some stocks as they added substantially to GALAPAGOS NV, SPRINGWORKS THERAPEUTICS INC (SWTX) and RELAY THERAPEUTICS INC (RLAY).
Finepoint Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that Finepoint Capital LP made a return of 0.94% in the last quarter. In trailing 12 months, it's portfolio return was 22.01%.
New Buys
| Ticker | $ Bought |
|---|---|
| qxo inc | 406,090,000 |
| calidi biotherapeutics inc | 14,249 |
New stocks bought by Finepoint Capital LP
Additions
| Ticker | % Inc. |
|---|---|
| galapagos nv | 2.76 |
| springworks therapeutics inc | 1.96 |
| relay therapeutics inc | 1.3 |
| argenx se | 0.74 |
| sarepta therapeutics inc | 0.53 |
| ascendis pharma a/s | 0.42 |
| revolution medicines inc | 0.34 |
| travere therapeutics inc | 0.31 |
Additions to existing portfolio by Finepoint Capital LP
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| churchill capital corp vii | -191,800 |
| concord acquisition corp ii | -44,917 |
| calidi biotherapeutics inc | -25,000 |
Finepoint Capital LP got rid off the above stocks
Sector Distribution
Finepoint Capital LP has about 49.4% of it's holdings in Technology sector.
| Sector | % |
|---|---|
| Technology | 49.4 |
| Others | 27.8 |
| Healthcare | 22.9 |
Market Cap. Distribution
Finepoint Capital LP has about 2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MICRO-CAP | 49.4 |
| UNALLOCATED | 27.8 |
| MID-CAP | 12.3 |
| SMALL-CAP | 8.5 |
| LARGE-CAP | 2 |
Stocks belong to which Index?
About 17.6% of the stocks held by Finepoint Capital LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 82.4 |
| RUSSELL 2000 | 17.6 |
Finepoint Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Finepoint Capital LP
Finepoint Capital LP has 24 stocks in it's portfolio. About 54.5% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. TVTX was the most profitable stock for Finepoint Capital LP last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 1.01 | 905,384 | 13,924,800 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 1.03 | 574,378 | 14,146,900 | unchanged | 0.00 | ||
| CDAQ | compass digital acquisition corp | 0.00 | 459,906 | 28,054 | unchanged | 0.00 | ||
| CNDA | concord acquisition corp ii | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVII | churchill capital corp vii | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 0.98 | 256,449 | 13,540,500 | unchanged | 0.00 | ||
| EYPT | eyepoint pharmaceuticals inc | 0.41 | 707,404 | 5,652,160 | unchanged | 0.00 | ||
| FLAG | calidi biotherapeutics inc | 0.00 | 12,500 | 14,249 | new | |||
| FLAG | calidi biotherapeutics inc | 0.00 | 655,200 | 8,583 | unchanged | 0.00 | ||
| FLAG | calidi biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GATE | marblegate acquisition corp | 0.00 | 735,000 | 25,284 | unchanged | 0.00 | ||
| IVCP | swiftmerge acquisition corp | 0.00 | 490,000 | 39,200 | unchanged | 0.00 | ||
| LBRDA | liberty broadband corp | 11.20 | 1,994,510 | 154,156,000 | unchanged | 0.00 | ||
| MLTX | moonlake immunotherapeutics | 1.43 | 388,835 | 19,605,100 | unchanged | 0.00 | ||
| PRTA | prothena corp plc | 0.53 | 433,471 | 7,251,970 | unchanged | 0.00 | ||
| RLAY | relay therapeutics inc | 0.84 | 1,626,150 | 11,513,100 | added | 1.3 | ||
| RVMD | revolution medicines inc | 2.41 | 731,960 | 33,194,400 | added | 0.34 | ||
| SLDB | solid biosciences inc | 0.49 | 961,251 | 6,699,920 | unchanged | 0.00 | ||
| SRPT | sarepta therapeutics inc | 1.21 | 133,535 | 16,677,200 | added | 0.53 | ||
| SSNT | qxo inc | 29.51 | 25,750,800 | 406,090,000 | new | |||